CELGENE THALIDOMIDE Trademark

Trademark Overview

On Monday, October 6, 2008, a trademark application was filed for CELGENE THALIDOMIDE with the United States Patent and Trademark Office. The USPTO has given the CELGENE THALIDOMIDE trademark a serial number of 77586151. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 15, 2016. This trademark is owned by Celgene Corporation. The CELGENE THALIDOMIDE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations used to treat cancers and immune related diseases
celgene thalidomide

General Information

Serial Number77586151
Word MarkCELGENE THALIDOMIDE
Filing DateMonday, October 6, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 15, 2016
Registration Number3634457
Registration DateTuesday, June 9, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2009

Trademark Statements

Disclaimer with Predetermined Text"THALIDOMIDE"
Goods and Servicespharmaceutical preparations used to treat cancers and immune related diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, January 15, 2016CANCELLED SEC. 8 (6-YR)
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 9, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, March 24, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 4, 2009NOTICE OF PUBLICATION
Tuesday, February 17, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 13, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 12, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, February 12, 2009ASSIGNED TO LIE
Thursday, February 12, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 12, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, February 12, 2009EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 28, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 27, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 27, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, December 1, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 1, 2008LETTER OF SUSPENSION E-MAILED
Monday, December 1, 2008SUSPENSION LETTER WRITTEN
Monday, December 1, 2008EXAMINER'S AMENDMENT ENTERED
Monday, December 1, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 1, 2008EXAMINERS AMENDMENT E-MAILED
Monday, December 1, 2008EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 25, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 25, 2008NON-FINAL ACTION E-MAILED
Tuesday, November 25, 2008NON-FINAL ACTION WRITTEN
Thursday, November 20, 2008ASSIGNED TO EXAMINER
Thursday, October 9, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

thalidomide celgene immune related diseases cancers treat preparations used pharmaceutical